DekaBank Deutsche Girozentrale - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 117 filers reported holding ANI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,341
+26.4%
23,022
+15.1%
0.00%
+50.0%
Q2 2023$1,061
+172.8%
20,000
+100.0%
0.00%
+100.0%
Q1 2023$389
-4.7%
10,0000.0%0.00%0.0%
Q4 2022$408
-99.6%
10,000
+189.9%
0.00%
Q3 2021$115,000
+2.7%
3,4500.0%0.00%
Q2 2021$112,000
-0.9%
3,4500.0%0.00%
Q1 2021$113,000
+16.5%
3,4500.0%0.00%
Q4 2020$97,000
+1.0%
3,4500.0%0.00%
Q3 2020$96,0003,4500.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders